<DOC>
	<DOCNO>NCT00280046</DOCNO>
	<brief_summary>This trial conduct Russian Federation . This trial aim comparison effect glycemic control subject type 2 diabetes three different treatment regimen : biphasic insulin aspart 30 thrice daily , biphasic insulin aspart 30 twice daily combination metformin treatment oral anti-diabetic drug .</brief_summary>
	<brief_title>Effect Biphasic Insulin Aspart 30 Blood Glucose Control Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin aspart , insulin aspart protamine drug combination 30:70</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Type 2 diabetes , currently treat one oral hypoglycemic agent HbA1c : At least 8.0 % Impaired hepatic , renal cardiac function</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>